Pharmaceuticals

Latest California Healthline Stories

FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns

The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.

Moved Overseas For School, Stayed For Insulin

Katie West, an American health researcher who has lived in Germany the past three years, hasn’t mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.

KHN’s ‘What The Health?’: Democrats Do Drugs (Prices)

House Democrats start legislative work on House Speaker Nancy Pelosi’s prescription drug pricing bill; health is again a featured player in the Democratic presidential candidate debate; and courts around the country hold up President Donald Trump’s health agenda. This week, Margot Sanger-Katz of The New York Times, Tami Luhby of CNN, and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Think ‘Medicare For All’ Is The Only Democratic Health Plan? Think Again

The Democratic presidential candidates have hit hard on health care, but generally the debates have centered on what kind of system candidates propose. The candidates’ ideas on many other issues, such as mental health and gun safety, have attracted much less attention.